Search for: "*u.s. v. Noonan"
Results 41 - 60
of 482
Sort by Relevance
|
Sort by Date
16 Nov 2021, 9:59 pm
Noonan -- The Federal Circuit continued its stringent (if misguided) application of the scope of subject matter eligibility by invalidating claims asserted in CardioNet, LLC v. [read post]
7 Nov 2021, 9:50 pm
In the webinar, entitled "Accepting the Status Quo: Subject Matter Eligibility Nearly a Decade after Mayo," Kevin Noonan and Donald Zuhn Jr. of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Cara Coburn of Genentech, June Cohan of the U.S. [read post]
7 Nov 2021, 9:50 pm
In the webinar, entitled "Accepting the Status Quo: Subject Matter Eligibility Nearly a Decade after Mayo," Kevin Noonan and Donald Zuhn Jr. of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Cara Coburn of Genentech, June Cohan of the U.S. [read post]
6 Nov 2021, 9:19 pm
In the webinar, entitled "Accepting the Status Quo: Subject Matter Eligibility Nearly a Decade after Mayo," Kevin Noonan and Donald Zuhn Jr. of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Cara Coburn of Genentech, June Cohan of the U.S. [read post]
6 Sep 2021, 9:59 pm
Bard, Inc. v. [read post]
17 Jun 2021, 9:01 pm
In Fulton v. [read post]
10 Jun 2021, 4:05 pm
Matter of Noonan, 17 B.R. 793, 800 (Bankr. [read post]
7 Jun 2021, 9:32 pm
Noonan -- In Becton, Dickinson & Co. v. [read post]
2 Jun 2021, 9:58 pm
Noonan -- Last week, the Federal Circuit affirmed imposition of an exclusion order under 19 U.S.C. [read post]
20 May 2021, 9:14 pm
Noonan -- The Federal Circuit continues its recent run of decisions extending the reach of the enablement requirement of 35 U.S.C. 112(a) to invalidate patents in Pacific Biosciences of California, Inc. v. [read post]
19 May 2021, 9:59 pm
Noonan -- Last month, the Federal Circuit affirmed an exclusion order imposed by the International Trade Commission against Bio-Rad for importing infringing microfluidic systems and components used for gene sequencing or related analyses, in Bio-Rad Laboratories, Inc. v. [read post]
25 Apr 2021, 9:51 pm
Noonan -- The Supreme Court heard oral argument last week in Minerva Surgical Inc. v. [read post]
23 Mar 2021, 8:49 pm
Noonan -- Ever since institution of the post-grant review proceedings enacted under the Leahy-Smith America Invents Act were implemented by the U.S. [read post]
10 Mar 2021, 8:53 pm
Noonan -- On March 1st, the U.S. [read post]
8 Mar 2021, 9:59 pm
Bayer Healthcare sued Defendants on U.S. [read post]
4 Mar 2021, 8:06 pm
Noonan -- On March 1st, the U.S. [read post]
2 Mar 2021, 8:38 pm
Noonan -- The Supreme Court heard argument on Monday in U.S. v. [read post]
21 Feb 2021, 9:59 pm
Noonan -- A little less than four years ago, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
17 Feb 2021, 9:09 pm
Noonan -- In a terse, non-precedential opinion, the Federal Circuit affirmed a district court's judgment that Defendants Torrent Pharmaceuticals and Indoco Remedies Ltd. had failed to prove that the claims asserted by Plaintiff/patentee Takeda were obvious, either under the statute or the judicially created doctrine of obviousness-type double patenting, in Takeda Pharmaceutical Co. v. [read post]
4 Feb 2021, 9:59 pm
Noonan, Michael S. [read post]
